Currently out of the existing stock ratings of Matthew Sharpe, 27 are a HOLD (43.55%), 4 are a SELL (6.45%), 31 are a BUY (50%).

Matthew Sharpe

Work Performance Price Targets & Ratings Chart

Analyst Matthew Sharpe works at MORGAN STANLEY with a stock forecast success ratio of 79.03% fulfilled within 180.67 days on average.

Matthew Sharpe’s has documented 129 price targets and ratings displayed on 12 stocks. The coverage is on Industrials, Technology sectors.

Most recent stock forecast was given on PL, Planet Labs PBC at 12-Jun-2023.

Wall Street Analyst Matthew Sharpe

Analyst best performing recommendations are on MAXR (MAXAR TECHNOLOGIES).
The best stock recommendation documented was for MAXR (MAXAR TECHNOLOGIES) at 12/14/2022. The price target of $42 was fulfilled within 2 days with a profit of $17.96 (74.71%) receiving and performance score of 373.54.

Average potential price target upside

BAH Booz Allen Hamilton CACI CACI International LDOS Leidos Holdings MANT ManTech International MAXR Maxar Technologies MEG Montrose Environmental Grp PAE PAE orporated PSN Parsons Corp SAIC Science Applications International Corp PRIM Primoris Services PRSP Perspecta PL Planet Labs PBC

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

136

$-11.32 (-7.68%)

104

2 months 16 days ago

2/3 (66.67%)

$-7.54 (-5.25%)

164

Hold

158

$10.68 (7.25%)

138

2 months 23 days ago

10/11 (90.91%)

$13.83 (9.59%)

200

Hold

145

$-2.32 (-1.57%)

120

2 months 24 days ago

11/11 (100%)

$1.11 (0.77%)

151

Buy

158

$10.68 (7.25%)

102

2 months 24 days ago

2/3 (66.67%)

$14.11 (9.81%)

224

Sell

125

3 months 17 days ago

6/6 (100%)

$5.26 (4.39%)

158

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Matthew Sharpe?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?